White Paper

Obesity in the workforce and GLP-1 medications

GLP-1 medications have the potential to provide substantial health benefits for injured workers who are overweight or obese.

However, key clinical considerations and evolving regulatory requirements surrounding this unique class of medications can make authorization and coverage decisions challenging for adjusters and payers.

Our clinical team and policy experts are prepared to help you navigate the everchanging landscape of GLP-1 medications while also focusing on best-in-class managed care strategies for your injured workers.

Read more to find out.

Download now opens in a new window